3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
18
Breast Neoplasms
17
Prostatic Neoplasms
10
Colorectal Neoplasms
9
Lung Neoplasms
8
Hematologic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Hematopoietic and Lymphatic System Neoplasm
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Sarcoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
Interventions
pembrolizumab
3
lenvatinib
2
Specimen Handling
2
Nivolumab
2
Cisplatin
2
trastuzumab deruxtecan
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
aldesleukin
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Positron-Emission Tomography
1
Platinum
1
Paclitaxel
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nelfinavir
1
Meperidine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Loperamide
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Standard of Care
×
90 days
×
Clear all
No trials found.